glp 1 agonist trials Another milestone in the evolution of GLP-1-based diabetes therapies How Can GLP-1 Agonists Be
Description
The treatment with semaglutide resulted in a lower energy intake and greater weight loss than placebo both in adults [31,34,35,36,37,39,61] and adolescents [49]
Some people experience persistent fatigue , headaches , or anxiety that does not resolve with dose adjustments
Both Drucker and Nauck expect this trend will continue, with the drugs eventually used to help control cardiovascular risk in people without either diabetes or obesity
Histochemistry 44: 281-290, 1975
